Reverse Metabolomics: New Method Finds Biomarker for Inflammatory Bowel Disease
UC San Diego scientists’ debut “reverse metabolomics,” a groundbreaking approach to advancing microbiome research. They use the technique to discover hundreds of new human molecules, and a new biomarker and therapeutic target for inflammatory bowel disease